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Lipid vesicle binding and modulation of membrane binding proteins and compounds. 
The lipid bilayer is an essential component of cells that separates the internal components to 
the external environment and also defines the internal components. Various proteins are 
utilized by the membrane for various cell processes including signaling, communication and 
responding to external signals. The interaction between cell membranes and proteins may 
have biological consequences [Lemmon MA, 20081], so studying these interactions allows a 
deeper understanding of biological processes and may reveal the pathogenesis of diseases 
related to these proteins. 
Class 1 Myosins are a group of actin based motor proteins associated with various roles related 
to membrane dynamics and trafficking. Their tail domain contains membrane binding regions 
such as the TH1 domain and a pleckstrin homology (PH) domain within the TH1.  
Alpha Synuclein is a predominantly presynaptic neuronal protein linked to several 
QHXURGHJHQHUDWLYHGLVRUGHUVVXFKDV3DUNLQVRQ¶VGLVHDVH,WKDVEHHQVKRZQWRLQWHUDFWZLWK
membranes and to associate with synaptic vesicles. In its physiological state, it has been 
shown to be acetylated, however the effect of this modification is still being investigated. 
Bacterial resistance to antimicrobials is becoming a significant challenge in effective treatment 
and prevention of bacterial infections worldwide, and the need for new antimicrobials is rising. 
For antimicrobials to be successful, they must initially penetrate and interact with the bacterial 
membranes in order to carry out their function. 
This project focused on the membrane binding effects of Myosin 1 and alpha Synuclein in order 
to determine their function and whether post-translational modifications impact these 
interactions. We also looked at antibiotic compounds to determine their membrane interactions 
using lipid vesicles as a model for the cell membrane and analyzing the interaction using 
stopped flow, DLS (dynamic light scattering) data and microscopy images. We successfully 
cloned and expressed both forms of the TH1 domain and were able to analyze the interaction 
between alpha Synuclein and vesicles. Our results suggest that the lipid composition of the 
vesicles affects their interaction with alpha Synuclein. Furthermore, acetylation of alpha 
Synuclein alters these interactions. 
 
                                                             
1 Lemmon MA. (2008) Membrane recognition by phospholipid-binding domains. Nature Reviews 
Molecular Cell Biology; 9: 99-111 
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1.1 - The Phospholipid Bilayer 
Cell membranes are essential for the structure and function of cells and organelles. 
They define internal components of cells, separate the internal and external 
environments and utilize various proteins for communication, signal response and 
mediating transport [1]. The fundamental building blocks of these membranes are 
amphipathic phospholipids [2] that are made up of a backbone (Figure 1), which can 
be either glycerol (named Glycerophospholipids or Phosphoglycerides) or sphingosine 

















Variations in the head groups and fatty acyl chains give rise to different phospholipids 
(Table 1) which allows them to have a large range of functions and to localize in a 
specific places [4]. The polymorphic capabilities of phospholipids allow them to form 
bilayers in physiological conditions, which are formed by the hydrophilic head group 
interacting with the aqueous environment and the hydrophobic tails repelling the 
aqueous environment and interacting with each other (Figure 2). This structure controls 
transportation across the membrane, provides fluidity, shape and stability to the 
membrane and allows proteins to be embedded within the membrane without 
adversely affecting the integrity of the membrane.  
 
Figure 1: The structure of a Glycerophospholipid. Glycerophospholipids are made 
up of a phosphate head group, fatty acids that can either be saturated or unsaturated 
and a glycerol molecule joining the hydrophobic and hydrophilic portions together. [2] 
 
Page | 9 
 
Table 1: Phospholipid head group and backbone variations. Different head groups, 
acyl chains and phospholipid backbones result in a variety of properties, functions and 
localization [2-6]. 
Head Group Backbone 
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1.2 ±Proteins and Binding sites 
Proteins are macromolecules that carry out many of the vital functions of cells. During 
protein folding, the specific amino acids that make up proteins gather together forming 
3-'VWUXFWXUHVWKDWFUHDWHWKHSURWHLQELQGLQJVLWHV7KHDPLQRDFLGVWKDWDUHQ¶WSDUWRI
the binding site provide a backbone or a support that allows the binding sites to fold 
into specific shapes, and so changing the amino acid sequence can change the 
structure and may therefore impact the binding site [6]. 
 
Figure 2: Self-assembly of phospholipids in a membrane. The bilayer is formed when 
the hydrophilic heads (red) interact with the external aqueous environment, whilst the 
hydrophobic tails (yellow) are repelled by the aqueous environment and interact with 
each other [2]. 
Figure 3: Diagram depicting Protein folding to form a binding site; specific 
amino acids gather together to form binding sites, and are held together by 
hydrogen bonds, the surrounding amino acids provide a backbone or support 
for the binding site [7] 
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All proteins bind to other molecules through the highly specific binding sites and the 
molecules a protein interacts with determines its properties. Binding to these molecules 
is dependent on the ability to form multiple weak non-covalent bonds with other 
molecules, again allowing for high specificity as the binding molecule (ligand) would 
need to closely fit the binding site in order to form these bonds. Proteins often contain 
several binding site so that they can be regulated and for localization, for example, the 
SH2 protein domain allows proteins to localize in plasma membranes in response to 
specific signals [7].  
1.2.1 ± Membrane Proteins 
 
Membrane associated proteins carry out the specific functions for membranes, 
including external signal response, transportation and mediating interactions between 
cells [8]. Like the phospholipids, they tend to be amphipathic; their hydrophobic regions 
interacting with the fatty acyl chains and hydrophilic regions interacting with the head 
regions. Membrane proteins are divided into two general classes; integral proteins and 
peripheral proteins which either interact with the membrane integral proteins or with 
the hydrophilic head groups [9].   
Integral or intrinsic membrane proteins are proteins that are embedded directly within 
the bilayer that can either span across the membrane (making them transmembrane 
Figure 4: Model of a typical membrane with associated proteins. A variety of amphipathic proteins 
can associate with the bilayer. They can be intrinsic proteins; whereby the protein is embedded within 
the bilayer with part of the protein exposed to the environment on one side or both sides of the bilayer 
(shown here are the blue, purple and yellow proteins). Or they can be external proteins that are bound 
to the membrane through the use of other intrinsic proteins or hydrophobic groups, which are the 
peripheral proteins (shown here by the pink and green proteins) [1]. 
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proteins) or are embedded on one side of the membrane [1]. Due to their ability to span 
across both hydrophilic and hydrophobic parts of the membrane, they tend to be 
amphiphilic. The fluidity of the membrane as well as their amphiphilic nature allows 
them to move freely within membranes and perform functions inside and outside of the 
cell. Integral proteins are involved in a variety of membrane related functions including 
cell adhesion, transportation and can act as receptors, enzymes and anchoring 
domains [8].  
Peripheral, or extrinsic membrane proteins are attached to the exterior of the 
membrane or associate with temporarily and without damage to the membrane. These 
proteins typically function as regulatory proteins, regulating processes such as cell 
signaling, enzymatic reactions and activation of membrane activity [1].  Due to their 
hydrophilic nature, they associate with membranes through intrinsic proteins 
embedded within the membrane or through electrostatic interactions with the 
negatively charged head groups, but do not interact with the hydrophobic core of the 
bilayer [8, 9].  
Outside of the protein-SKRVSKROLSLG ELOD\HU LV D FRDW WHUPHG WKH ³*O\FRFDO\[´ Dn 
external coat made up of carbohydrate chains that has a variety of functions including 
providing protection for the cell from damage, retaining moisture and in some cases 
PHGLDWLQJWKHFHOO¶VLQWHUDFWLRQV [10, 11]. 
 
 
1.2.2 ± Post translational modifications 
Protein regulation is essential, as it allows proteins to be rapidly adaptable to their 
environments and allows cells to specialize. Post-translational modifications are 
protein modifications that occur after translation, whereby functional groups are 
covalently added to the protein.  These include phosphorylation, acetylation and 
ubiquitination, and are often used in protein regulation within cells [12].  
Phosphorylation is the reversible addition of a phosphate group to an amino acid chain 
of a protein. This happens when the terminal phosphate group on ATP is attached to 
a hydroxyl group (catalyzed by Protein Phosphatase) forming ADP and the 
phosphorylated protein [12]. Each phosphate group carries a 2+ charge, which 
changes the overall charge of the protein and can either change the molecules the 
protein binds to or change a binding site on allosterically, which can then affect the 
activity, structure and localization of the protein. Both phosphorylation and de-
phosphorylation can be used to turn proteins on or off, allowing the protein to be 
regulated [1] (Figure 3). 
Page | 13 
 
 
Another post-translational modification used by cells is acetylation. This is the addition 
of an acetyl group from acetyl co-enzyme A to a protein. Similar to phosphorylation, 
this allows the cell to respond to specific signals and adapt to its environment quickly 
[12]. Acetylation occurs in two forms: N-terminal acetylation, which is catalyzed by N-
terminal acetyltransferases (NATS) and ࣅ-amino group acetylation of lysine (which is 
less common) [13].  
Defects in posttranslational modifications have been linked to diseases, which has led 
to further research into the effect of these modifications on different proteins. The TH1 
domain of Myosin 1 and Alpha synuclein (Į6\QXFOHLQ) are discussed in this study. 
1.3 ± Myosin 
The myosin superfamily are a group of ATP dependent motor proteins that are involved 
in motility functions [14], most commonly known for muscle contractions. The majority 
of Myosins localize in the cytoplasm, however some have been found to localize in the 
nucleus as well, carrying out a range of functions [15]. Some are ubiquitous whilst 
others are specialized in specific cells, such as mediating cell division, enabling 
neuronal structural changes and muscle movement and contraction. Although there 
are many types of myosin with differing functions, they all share the same basic 
properties; all bind to the cytoskeletal protein actin, converting energy from ATP 
hydrolysis into mechanical movement to carry out various functions [16-18]. Actin is an 
abundant protein in eukaryotic cells, with the ability to form microfilaments and thin 
filaments. Microfilaments are part of the cytoskeleton whereas thin filaments are found 
in muscle cells and involved in muscle contractions. 
Figure 5: Diagram depicting protein phosphorylation; phosphorylation of proteins is 
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1.3.1 ± The Myosin Binding Cycle 
Myosins walk along these actin filaments in the cytoskeleton and muscle cells, 
generating mechanical force and allowing movement. Most of the internal and external 
movements of the body are dependent on this interaction between Myosins and the 
actin. This interaction involves Myosin molecules undergoing conformational changes, 
FRXSOHGZLWKDQLQFUHDVHLQWKHK\GURO\VLVRI$73WKDWHQDEOHVWKHPWR³ZDON´RUVOLGH
DORQJ DFWLQ ILODPHQWV WRZDUGV WKH SRVLWLYHO\ FKDUJHG HQG XVLQJ WKH ³Power stroke´
mechanism [19] which is regulated by calcium ion concentration.  A complete round of 
ATP hydrolysis produces a single step or movement along the actin filament. Myosins 
differ in the way they move along the actin filaments, with some found to even move 
towards the negatively charged end of actin, however all follow the same basic cycle. 
Alongside this, Myosins may pull on membranes to change their shape, cause muscle 
contractions, form tubules along filaments or transport vesicles, lipids and associated 
proteins along actin molecules [19]. 
 
Figure 6: Diagram depicting tKH³3RZHUVWURNH´PHFKDQLVPRI0\RVLQVDORQJDFWLQILODPHQWV
Unbound myosin is attached to actin, resulting in a conformational change in the myosin molecule. ATP 
then binds to myosin head domain, inducing a small conformational shift in the actin binding site, leading 
to myosin releasing the actin filament. 2. ATP binding also causes the neck region of myosin to bend and 
position itself further along the filament. 3. ATP is then hydrolyzed, creating ADP and an inorganic 
phosphate that are still bound to myosin. 4. Myosin weakly interacts with actin, causing a conformational 
change in the myosin head. 5. Myosin releases Pi, then binds to Actin once again, triggering the power 
stroke; the force generating step. 6. Myosin then reverts back to its original conformation and releases 
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1.3.2 ± Myosin Domains and Subdomains 
All Myosins are made up of 3 separate domains with specific functions; a globular head 
domain (the N terminal), a neck region and a C-terminal tail region [20].  
The motor domain (N-terminal) or the head group, is a generally conserved [20] actin 
and ATP binding domain made up of 4 subdomains. Isoforms arise from differences in 
their ability to produce a force against an external load, their regulation and consecutive 
steps of movement. Some Myosins have single heavy chains, contacting the actin 
filaments at one site only, while others have two heavy chains which contact Actin on 
multiple sites [20]. High processive motors (generally polymeric myosin heads) are 
generally involved in the transportation of cargo whereas low duty motors (monomeric 
motors) are better suited to rapid movements and contractions of actin [15]. 
 
Figure 7: Diagram depicting Myosin Head domain variation. All Myosins have a 
conserved head domain, where the actin binding site is located, and can vary in the number 
of heavy chains and thus the number actin binding sites. [15] 
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Attached to the head domain, it the neck region [21], an alpha helical domain that links 
the head and the tail domain and regulates Myosin through the use of calmodulin or 
calmodulin-like light chains [22, 23]. The neck domain acts as a lever arm for the motor 
domain during the power stroke mechanism, as step size of myosin is linearly related 
to the length of the neck region [21]. The number and size of light chains attached 
influence the length of the neck region and therefore the step size of the myosin 
molecules [20]; the longer the neck domain, the larger the step size. This allows 
different Myosins to have different functions; larger step sizes being more suitable for 
sustained binding or transportation of cargo and shorter step sizes being ideal for rapid 
movements or contractions [21, 24]. Light chains also vary in their mechanism and 
responses, however all use Ca2+ ion concentration for regulation. An example of these 
is Calmodulin (CaM), a protein that binds to up to 4 calcium ions (Ca2+), causing 
conformational changes in CaM, which can either inhibit or activate Myosin, allowing it 
to be regulated [25-27].  
Finally, attached to the neck region is the C-terminal tail domain; the most diverse 
domain in Myosins. Within the tail domain are regions that determine the function and 
target of Myosins [18], such as the motor and tail homology 1 domain (TH1) [28]. These 
subdomains allow them to interact with specific phospholipids and carry out various 
functions on the cell surface.  
The TH1 region contains positively charged regions that electrostatically interact 
directly with negatively charged phospholipids on cellular membranes which allows 
them to localize in specific areas. For many molecules, the TH1 domain is essential in 
localization and function [28]. The TH1 domain contains many regions such as the 
Pleckstrin Homology domain (PH domain), two membrane-binding regions known as 
N and C terminal targeting motifs that have been shown to mediate Myosin specificity 
and binding [29], thereby allowing the TH1 region to regulate the dynamics of Myosin 
[29]. Other regions include the TH2 region, which has been shown to be a non-ATP 
sensitive secondary actin binding site, and the TH3 (or SH3) domain [30], which has 
been shown to organize the actin cytoskeleton, is associated with signal induction and 
mediate protein-protein interactions by binding to proline-rich structures [31]. The 
myosin tail can be subdivided into long tailed isoforms and short tailed isoforms that 
contain the TH1 domain only [28]. 
The pleckstrin homology domain (PH domain), has drawn research interest due to its 
ability to interact with Phosphatidylinositol lipids in membranes and proteins [29]. For 
the most part, this domain interacts in a phospholipid specific manner that may give an 
indication into the function of certain myosin molecules [29]. PH domains with high 
affinity have proven to be useful tools in studying biological membranes; when 
attached to GFP, they allow us to analyze specific phospholipid distribution in cellular 
membranes. The PH domain is usually implicated in intracellular signaling, the 
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recruitment of proteins to specific membranes allowing them to localize and carry out 
specific functions there, or as a part of the cytoskeleton [29].  
7KH3+GRPDLQ LVPDGHXSRI WZRSHUSHQGLFXODUDQWLSDUDOOHOȕVKHHWV WKDWGLIIHU LQ
length for different isoforms of the PH domain, followed by a c-terminal amphipathic 
helix that contains a single highly conserved tryptophan. The function of many PH 
domains, although highly studied, is still unclear [29].  
The tail domain provides another mechanism for some Myosins to be regulated called 
³WDLOLQKLELWHGUHJXODWLRQ´>@,QWKLVPRGHO0\RVLQWDLOVKDYHFRQIRUPDWLRQVRSHQ
and folded. When folded, the tail domain interacts with the head domain thereby 
inhibiting its activity. However when cargo binds or in high Ca2+ concentrations, the 
Myosin becomes open and reduces its interaction with the head domain [33].  
Myosins can be divided into two subcategories; conventional and unconventional 
myosin, determined by their ability to form filaments [16, 28]. Myosin II, one of the most 
abundant and most commonly known Myosins, is a conventional myosin. Myosin II is 
involved in muscle contraction and also in driving and mediating motile events in cells. 
Unconventional Myosins generally have globular head domains and are involved in 
processes such as endocytosis, intracellular transport, and formation of cell 
protrusions and gating of ion channels. A common unconventional myosin, and the 
focus of this study, is Myosin 1. 
1.3.3 ± Myosin 1 
Myosin I (Myo1) proteins are a widely expressed, diverse group of a small monomeric 
proteins, involved in membrane related processes [28]. They have been shown to 
associate with cellular organelles such as the Golgi, and dynamic membrane events; 
endocytosis, exocytosis, membrane trafficking, sensory transduction, cell shape 
control, cell adhesion [28, 34]. Myosin 1 have also been shown to interact with 
electrostatically with specific phospholipids [17], however their exact mechanism of 
action is still unclear, as is their regulation. As they are slow, low duty motor, they are 
not suited for long range movement or binding, so they exploit diffusion for proper 
localization and are used in transportation. Isoforms of Myosin 1 have been shown to 
have differing functions, for example Myo1a has been implicated in the secretion of 
lysosomal enzymes [34], whereas Myo1c has been shown to be essential in hearing 
[35], and other myosin isoforms are involved in the transportation of vesicles [36].  
Myosin 1 is also found in intestinal brush border cells, where it is involved in 
membrane-cytoskeletal adhesion to stabilize microvilli [28]. 
Myosin 1, like other Myosins, can be regulated not only by a calmodulin related light 
chain, but also by N-terminal phosphorylation, which has attracted much research 
interest as the both the exact mechanism and the effect that this phosphorylation has 
on binding are not fully known. 
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1.4 ± Alpha Synuclein 
3DUNLQVRQ¶VGLVHDVH3'LVDSURJUHVVLYHQHXURORJLFDOFRQGLWLRQFDXVHGE\DORVs of 
nerve cell function and dopamine, a neurotransmitter that regulates movement in the 
body, the Substantia Nigra. PD is more commonly known by symptoms such as rigidity, 
stiffness and tremors, however its pathogenesis is still unclear. Alpha Synuclein (Į-
Synuclein), a presynaptic neuronal protein, has been linked to the pathogenesis of PD 
due to its high prevalence in Lewy bodies (abnormal protein deposits) and its ability to 
form aggregates [37, 38].  It is abundantly expressed in the nervous system, found 
close to synaptic vesicles, however, has also been found in erythrocytes and platelets, 
for unknown reasons [39].  
Į-Synuclein is coded for by the SNCA gene [37], and several mutations of this gene 
have been linked to some cases of PD as they cause incorrect folding or an 
overproduction of Į6\QXFOHLQ [37]. 7KHPLVIROGHGRUH[FHVVĮ6\QXFOHLQ LV WKRXJKWWR
cluster and form aggregates, impairing neuronal function, which is then thought to lead 
WR3'Į6\Quclein may also cause dopamine to accumulate at presynaptic terminals, 
leading to a loss of communication between neurons therefore causing involuntary 
movement of muscles [40].  
The precise role of Į6\QXFOHLQ in the development of PD remains unclear, as is its 
physiological function [37], however studies suggest it may play a role in maintaining 
vesicles at presynaptic terminals by aggregating them together, or in the regulation of 
neurotransmitter release [37, 41]. Although it is natively unstructured in the cytosol, 
ZKHQLQWHUDFWLQJZLWKPHPEUDQHVĮ6IRUPVDQDOSKDKHOLFDOVWUXFWXUHWKDWFDQOHDGWR
the formation of oligomers [42].  
Three distinct regions PDNHXSĮ6DQDPLQRWHUPLQDO with lipid binding motif, a central 
hydrophobic domain called the NAC region, which distinguishes it from the other 
members of the Synuclein family, and an acidic C-WHUPLQXVRU³WDLO´UHJLRQ>]. The N-
terminal domain is positively charged and it thought to interact with anionic 
phospholipids reversibly.  
7KHVWDELOLW\DQGIROGLQJRIĮ6DQGLWVPHPEUDQHUHODWHG IXQFWLRQVDUHVXEMHFW WRD
variety of post translational modification such as N-terminal acetylation and 
ubiquitination [43]. N-terminal acetylation of Į6\QXFOHLQ has recently drawn research 
DWWHQWLRQ,QLWVQDWLYHVWDWHĮ6\QXFOHLQKDVEHHQIRXQGWREH1-terminally acetylated 
and this is thought to regulate its activity. Several models for Į6\QXFOHLQSDWKRJHQHVLV
have surfaced [44-46] and multiple mutations have been linked to PD [47]. 
6HYHUDO QHXURGHJHQHUDWLYH GLVHDVHV VXFK DV 3' $O]KHLPHU¶V GLVHDVH DQG
+XQWLQJWRQ¶VGLVHDVHKDYHEHHQVKRZQWRKDYHVLPLODUSDWKRORJLHVPLVIolded proteins 
accumulating to form aggregates leading to neurological degeneration. As this 
suggests a similar pathogenic mechanism [48-50], understanding the physiological 
IXQFWLRQ RI Į6\QXFOHLQ PD\ give insight into involvement in PD pathogenesis, thus 
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allowing us to better understand these other diseases. This could also lead to more 
effective treatments for these diseases or potentially a cure for these diseases. 
1.5 ± Aim of this study 
The interaction between cell membranes and proteins, in particular peripheral proteins, 
may have an effect on the membrane dynamics and morphology, and therefore has 
biological consequences [Lemmon MA, 2008]. The study of these interactions allows 
a deeper understanding of biological processes and also allows us to determine the 
pathogenesis of diseases related to these proteins. The aim of this project was to 
determine how various membrane binding proteins interact with specific phospholipids 
and how the post-translational modifications acetylation and phosphorylation impact 
their interactions. Therefore, in this study, we will be looking at how the acetylation of 
Į6\QXFOHLQ, and similarly how phosphorylation of the TH1 domain of Myosin 1, impact 
their membrane interactions.  
  






            Materials and Methods  
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2.1 - Materials 
2.1.1 ± Bacterial Strains 
Escherichia coli: DH10B, BL21 (DE3) PlysS and BL21 (DE3) Cam1 Rosetta competent 
were used in transformations for plasmid DNA isolation and protein induction. 
2.1.2 ± Buffers and Media 
Luria-Bertani (LB) Media 
1 liter of LB was made using 5 g Yeast extract, 10 g Tryptone and 10 g Sodium Chloride 
added to 1 Liter of dH2O [51]. This was then stirred using magnetic stirrer until 
dissolved and then poured into desired bottles or flasks to be autoclaved. 
Vesicle Buffer A 
Made up of 0.005M NaH2PO4 and 0.5M NaCl in dH2O and pH adjusted to pH 7.2 
Native Lysis Buffer B 
Made up of 5mM MgCl2, 50mM NaH2PO4, 300mM NaCl and 10mM Imidazole in 
dH2O and pH adjusted to pH 8.0 
Native Wash Buffer B 
Made up of 50mM NaH2PO4, 300mM NaCl and 20mM Imidazole in dH2O and pH 
adjusted to pH 8.0 
Native Elution Buffer B 
Made up of 50mM NaH2PO4, 300mM NaCl and 500mM Imidazole in dH2O and pH 
adjusted to pH 8.0 
Native Binding buffer A 
Made up of 50mM Tris Base, 500mM NaCl and 10mM Imidazole in dH2O and pH 
adjusted to pH 7.8 
Native Wash Buffer A 
Made up of 50mM Tris Base, 500mM NaCl and 10mM Imidazole in dH2O and pH 
adjusted to pH 6.0 
Native Elution Buffer A  
Made up of 50mM Tris Base, 500mM NaCl and 150mM Imidazole in dH2O and pH 
adjusted to pH 6.0 
Column Wash 
Made up of 20mM MES, 30mM NaCl in dH2O and pH adjusted to pH 5.0 
Denaturing Buffer B 
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Made up of 7M Urea, 0.1M NaH2PO4 and 0.01M Tris base in dH2O and pH adjusted 
to pH 8.0 
Denaturing Buffer C 
Made up of 8M Urea, 0.1M NaH2PO4 and 0.01M Tris base in dH2O and pH adjusted 
to pH 6.3 
Denaturing Buffer E 
Made up of 8M Urea, 0.1M NaH2PO4 and 0.01M Tris base in dH2O and pH adjusted 
to pH 4.5 
SDS Page Buffer 
TAE Buffer 
2.1.3 - Gene constructs 
The Hum-1 TH1 and Hum-1 C-terminal genes from C-elegans were used to create the 
following constructs using the pTOPO2.1 vector (Invitrogen).  
v833 - pET151DTOPO_Nde1hum1TH1 (717-912) BamH1 (WT TH1) 
v839 - pET151DTOPO_Nde1hum1 (717) TH1-End BamH1 (WT C-terminal) 
v884 - pET151DTOPO_NcoImNeongreen-Nde1hum1TH1 (717-912) BamH1 (Neon 
green WT TH1) 
Phosphomimetic mutants 
V875-6 - pET151DTOPO_Nde1hum1TH1S782A (717-912) BamH1  
v877 - pET151DTOPO_Nde1hum1TH1S782D (717-912) BamH1 
v886 - pET151DTOPO_NcoImNeongreen-Nde1hum1TH1 (717-912) S734D BamH1 
(Neon Green D 
Each construct was checked once generated using a restriction enzyme digest and 
then run on an Ethidium Bromide gel, if successful, then sequenced. 
The Į6\QXFOHLQ construct v696 - pETDuet-1_aS-Cerulean3 was created by another 
member of the lab. The isoforms of ĮS were generated by transforming the construct 
into different competent cells. For acetylated ĮS, E. coli BL21 NatB cells were used, 
whereas the un-acetylated ĮS was formed using BL21 DE3 pLysS cells.  
2.1.4 ± DNA and Protein Ladders (Molecular Markers) 
- PageRulerTM Unstained Protein Ladder 
- New England BioLabs (NEB) 1 kb DNA ladder  
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2.2 - Methods 
2.2.1 ± Cell Cultures 
E. coli cultures 
E. coli cultures were made up using 5ml of Luria-Bertani Media and grown to an optical 
density at 595nm of 0.4.   
2.2.2 ± Cloning  
Transformations 
An aliquot of competent cells were defrosted on ice. 3 µL of desired plasmid was added 
and mixed gently using a pipette tip. Cells were incubated on ice for 30 minutes before 
subjecting them to a 90 second heat shock at 42°C then returned to ice for  2 minutes. 
100 µL LB was added and then incubated at 37°C while shaking for 1 hour. Cells were 
plated onto LB agar plate with 5 µL of antibiotic, then incubated overnight at 25°C. 
Cloning and expressing the TH1 and Full length tail 
The Hum 1 gene from Caenorhabditis elegans (C. elegans) was used to clone the TH1 
domain and the full length tail. 
Three sets of oligonucleotides (602, 603 and 604) were created from the Hum 1 gene 
sequence and ordered from IDT. The oligonucleotides were then diluted to a final 
concentration of 1µg/µL and mixed as follows:  
TH1 Domain: 1ul of oligo 602 was added to 1ul of oligo 604 with 8ul of dH2O 
Full length tail: 1ul 602 was added to 1ul of oligo 603 with 8ul of dH2O 
High infidelity PCR was conducted on these and then both the TH1 domain and full 
length tail plasmids were transformed into E. coli BL21 DE3 pLysS cells to express this 
protein for further experiments. 
Neon Green TH1 
Ligation A 
6µL dH20, 1µL T4 Ligase Buffer, 1µL TH1 PCR product, 1µL Pgem Vector and 1µL of 
DNA Ligase 
Ligation B 
2µL dH2O, 1µL T4 Ligase Buffer, 5µL PCR product, 1µL Pgem Vector and 1µL of DNA 
Ligase  
Ligations were set up as stated above and incubated at 16 °C overni ght then heat 
inactivated at 65 °C for 10 minutes the following day.  A transform ation was carried out 
as normal using DH10B cells, and transformants were plated on LB plates with 5µL 
Ampicillin, IPTG and Xgal. 
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2.2.3 ± DNA Protocols 
DNA Extraction and Purification 
4LDJHQ¶V 4,$TXLFN JHO H[WUDFWLRQ NLW DQG PLQLSUHS NLW ZHUH XVHG DFFRUGLQJ WR WKHLU
instructions [52]. 
Agarose gel electrophoresis (Ethidium Bromide) 
Agarose powder was weighed into an Erlenmeyer flask and dissolving into the 
appropriate volume of TAE Buffer to make a 0.5% Agarose gel. The agarose-buffer 
mixture was melted, swirling to mix at regular intervals, and allowed to cool slightly. 
Ethidium Bromide was added to a final concentration of 0.5 µg/ml and the molten gel 
was poured into a gel casting tray. Any air bubbles were removed using a pipette tip, 
then a gel comb was carefully placed along the top of the gel to create wells. The gel 
was allowed to set at room temperature, then comb was carefully removed and the gel 
was placed in the gel tank with TAE buffer. Gels were run either 50V for 60 minutes or 
100V for 30 minutes then visualized under a UV lamp and imaged. 
PCR 
PCR was carried out under the following conditions and then run on an Ethidium 
Bromide gel to determine whether product was present: 
Hot start 
92Ԩ for 30 seconds 
45Ԩ 30 seconds 
72Ԩ 1 minute 
Repeat steps 2-4 25 times 
 
2.2.4 ± Protein Protocols 
Protein Induction 
Overnight cultures were set up and used the following day.  
Small scale induction 
20 ml of LB was poured into a 50 ml Falcon tube with 20µL of each antibiotic needed. 
200µL of the overnight culture was added and the falcon tube was incubated at 37°C 
with shaking. When the culture had reached an optical density of 0.4 abs at 595 nm, a 
1 ml sample was taken and kept for SDS PAGE analysis, then 20µL of IPTG was 
added to the culture and incubated at 37°C with shaking for 2-4 hours.  
After induction, cells were harvested by centrifugation at 4600 rpm for 30 minutes at 
4°C. Pellets were stored at - 20°C until required.   
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Large Scale Induction 
1 Liter of LB was divided into two 2 Liter conical flasks, a sponge stopper and tin foil 
were placed in the top of the flasks. The LB was autoclaved for 20 minutes and once 
cool, 500 µL of each antibiotic required were added to each flask along with 5 ml of the 
overnight culture. The cultures in the flasks were then incubated at 37°C with shaking 
until they had reached an optical density of 0.4 at 595 nm, a 1 ml sample was taken 
and kept for SDS PAGE analysis and 500µL IPTG was added to each flask. The 
cultures were incubated for another 2-4 hours at 37°C with sh aking, then cells were 
harvested by centrifugation at 8000 rpm for 20 minutes at 4°C. Pelle ts were stored at 
-20°C until required.    
SDS PAGE Analysis 
1 ml samples were extracted every hour after IPTG was added, their optical density 
was recorded and then the samples were centrifuged in Eppendorfs and pellets were 
used for SDS PAGE analysis. The optical density of the samples was multiplied by 100 
to give the volume of PBS needed to re-suspend them in µL. ¼ of that volume of protein 
loading buffer was added to the solutions and the protein was denatured by heating at 
95°C. 20 µL of each sample was run on an SDS PAGE gel. 
Protein Purification 
Preparation under Native Conditions 
Protein pellets were thawed and re-suspended at 2-5 ml per gram weight of either the 
Native Binding Buffer A or Native Lysis Buffer B. Lysozyme was added to a final 
concentration of 1mg/ml and incubated for 30 minutes on ice. The solution was then 
sonicated in six 30 second bursts with 1 minute intervals, then poured into a centrifuge 
tube and centrifuged at 4600 rpm for 20 minutes at 4Ԩ. The supernatant was collected 
and 1µL DNase and 1µL RNase were added then incubated on ice for 15 minutes. 
Protein was isolated by centrifugation at 10000 rpm for 20-30 minutes at 4°C. The 
supernatant and pellet were carefully separated and the supernatant was kept for 
purification. 20 µL of each were run on an SDS PAGE gel to check solubility. 
 Purification under Native conditions using a Cobalt Column 
Native Binding Buffer A was used to re-suspend frozen protein pellet.  
Tweezers were sterilized using Ethanol and a Bunsen flame and a small amount of 
sterile cotton was taken out using the sterilized tweezers and pushed into the bottom 
of a sterile 10 ml needleless syringe. Distilled water was pipetted into the syringe and 
then pushed down used the plunger, creating a stopper that would prevent the resin 
from escaping through the syringe. The syringe was then clamped onto a clamp stand 
and a small cap was placed on the lip of the syringe. 2 ml of Metal Affinity Cobalt Resin 
was slowly pipetted into the column and allowed to settle, then the cap was removed 
and the storage fluid was allowed to slowly drip out. 6 ml of water was used to settle 
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the resin and wash out the storage fluid. 10 ml of Native binding buffer A was slowly 
and gently pipetted into the syringe, and allowed to drip through, so as to calibrate the 
FROXPQHQVXULQJWKHJHOGRHVQ¶WGU\RXW7KHFDSZDVUHSODFHGRn the lip of the syringe 
and 2 ml of Native Binding Buffer A was added to the top of the gel.  
Once sample was prepared, it was loaded slowly into the column, without disturbing 
the resin. The cap was again removed and the sample was allowed to drip through the 
resin and caught in bijou tubes. The His-Tagged protein should have bound to the 
cobalt resin at this point. Native wash buffer A was then pipetted slowly 1 ml at a time, 
up to a total volume of 10 ml, to wash out unbound protein which was caught in bijou 
tubes. Once all the wash buffer had run through, the cap was placed on the lip of the 
syringe to stop the gel from drying out. 10 ml of Native elution buffer A was pipetted 
gently into the column. The cap was removed and ten 1 ml elutions were collected and 
all bijou tubes were clearly labelled. 20µL from each sample was taken and saved in 
an Eppendorf to run on an SDS-PAGE gel. The column was then washed through with 
Native binding Buffer A and the cap was replaced on the lip of the syringe. 2-5 ml of 
native binding buffer with 0.02% Sodium Azide was poured into the syringe and both 
ends were wrapped in parafilm. The reusable column was stored at 4°C.  
Purification under Native conditions using Qiagen Ni-NTA Spin Kit 
Native Lysis Buffer B was used. 
The spin columns were equilibrated using 600 µL of Lysis Buffer B, centrifuged at 2900 
rpm and the buffer was discarded. 600 µL of supernatant was loaded onto spin column, 
centrifuged for 5 minutes at 1600 rpm and supernatant was collected for SDS PAGE 
analysis. Spin columns were washed with 600 µL Native wash buffer B and centrifuged 
at 2900 rpm twice and washes were collected for SDS PAGE analysis. 300 µL Elution 
buffer was loaded onto spin column then centrifuged at 2900 and this was repeated 
three times. 20 µL samples of the elutions were taken for SDS PAGE analysis. 
Protein preparation under denaturing conditions 
Frozen protein pellets were thawed on ice for 15 minutes then resuspended in 
Denaturing Buffer B at 5 ml per gram weight. Protein solutions were incubated at 25°C 
with shaking for 1 hour, then centrifuged at 10,000 rpm for 20-30 minutes at 25°C. The 
supernatant was saved for purification.  
Protein purification under denaturing condition using Qiagen NI-NTA Spin Kits 
The spin columns were equilibrated using 600 µL of denaturing Buffer B, centrifuged 
at 2900 rpm and the buffer was buffer was discarded.  600 µL of supernatant was 
loaded onto spin column, centrifuged for 5 minutes at 1600 rpm and the supernatant 
was collected for SDS PAGE analysis. Spin columns were washed three times with 
600 µL of Denaturing Buffer C, centrifuged at 2900 rpm and washes were collected for 
SDS PAGE analysis. 300 µL
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and allowed to settle for 1 minute. The spin column was then centrifuged at 2900 and 
the elution was kept in an Eppendorf. 5-6 Elutions were collected and 20 µL of each 
sample was kept for SDS PAGE analysis.  
Protein refolding for purification under denaturing conditions 
Protein was dialyzed into 5 Liters of Vesicle Buffer, with gradually decreasing urea 
concentrations over 2 days.  
SDS PAGE Analysis  
A 10% SDS-PAGE Gel was made up as follows: 
Resolving gel  
2.55 ml dH΍O, 3.75 ml 1.5M TRIS pH 8.7, 100µL of 10% SDS, 3.2 ml of 30% Sigma 
Aldrich Acrylamide/Bis-acrylamide, 100µL Aps and 15 µL TEMED. 
Stacking gel 
7ml dH΍O, 1.25 ml 1M TRIS pH 6.8, 50 µL  of 10% SDS, 1.7ml of 30% Sigma Aldrich 
Acrylamide/Bis-acrylamide, 50 µL APS and 15 µL TEMED. 
Both gels were set in the 37 °C incubator. 
 
2.2.5 ± Vesicle Protocols 
DLS 
We used the Malvern Zetasizer Nano DLS and program, all DLS experiments were run 
in Vesicle Buffer A at 25ºC. 
For Vesicle controls 
1.1ml of vesicles was pipetted into the DLS cuvette and measured using the Malvern 
Nano program.  
For Vesicles with protein 
1 ml of vesicles and 100 µL of protein were pipetted into the DLS cuvette and measured 
using the Malvern Nano program. 
Vesicle Preparation by Extrusion 
Preparation of Vesicles  
Lipids were weighed to make up 1 mM lipid suspensions and chloroform to the 
appropriate volume was added. Lipid suspensions were dried on a rotary evaporator 
at 20°C until all the chloroform had evaporated then placed on  a vacuum line to remove 
any remaining chloroform. Lipids were rehydrated with the appropriate volume of 
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Vesicle Buffer A to make a 1mM solution then bath sonicated, ensuring all the lipid has 
been removed from the bottom of the flask. Nine freeze-thaw cycles were then carried 
out using liquid nitrogen and a room temperature water bath. If storing the lipid for later 
use, do not complete the last thaw cycle. 
Extrusion 
The lipid solution was allowed to stand at room temperature for 30 minutes then using 
$YDQWL¶V([WUXVLRQNLWYHVLFOHVZHUHSXVKHGWKURXJKQPPHPEUDQHDQGSODFHGLQ
a glass vial. 
 
2.2.6 ± Stopped Flow Protocol 
All kinetic experiments were conducted in Vesicle Buffer A at 20Ԩ. Measurements 
were performed with a High-Tech Scientific stopped flow system. The concentrations 
stated are those before mixing in the stopped flow observation cell. All stopped flow 
traces were analyzed by TgK (Kinetic Studios). Cerulean fluorescence was measured 
by excitation at 436 nm and Light scattering was measured at 545 nm using the GG-
455 optical filter. The time-dependent data were best fit to a double exponential 
function showing two distinct phases of the reaction; a rapid initial phase and a second, 
more gradual phase 
 
2.2.7 - NI-NTA Magnetic Bead Assay 
Ni-NTA Magnetic Agarose Beads from Qiagen were used for this assay. 
Protein binding 
7KH PDJQHWLF EHDGV ZHUH UHVXVSHQGHG LQ WKH PDQXIDFWXUHU¶V EXIIHU WKHQ SODFHG
immediately on a magnetic separator and the buffer was carefully removed using a 
pipette. The beads were then re-suspended in 1 ml of Vesicle Buffer A, mixed 
thoroughly and placed on the magnetic separator. The buffer was again removed and 
the beads were resuspended in 1 ml Vesicle buffer A. This was repeated once more 
and then the Agarose bead solution was mixed thoroughly by vortexing for 20s. 
Immediately, 250 µL of the Agarose bead solution was pipetted into 4 separate 1.5ml 
eppendorfs. 250 µL of the TH1 protein in Vesicle Buffer A was added to 3 of the 
eppendorfs with 500 µL of Vesicle Buffer A to make up a total volume of 1 ml. A 
negative control was set up by adding 750 µL of Vesicle Buffer A to the agarose bead 
solution in one of the eppendorfs. All 4 eppendorfs were incubated with stirring at 4°C 
for 1 hour to ensure the protein was bound to the agarose beads. The solutions were 
thoroughly mixed by vortexing once again and then placed on the magnetic separator. 
All of the buffer was removed carefully, with the unbound protein and saved in separate 
Eppendorf tubes. The magnetic beads were washed through with Vesicle Buffer A 
twice, placed on the magnetic separator and the solution was removed.  
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Vesicle Binding 
500µL of vesicles suspended in Vesicle Buffer A were added along with 500µL of the 
buffer to make up a total volume of 1 ml and mixed thoroughly. The eppendorfs were 
incubated on a 4Ԩ shaking stirrer overnight, to allow time for the vesicles to bind to the 
protein. The solution and beads were separated using the magnetic separator and then 
the solution was removed and pipetted into a separate Eppendorf. The beads were 
then washed through with Vesicle Buffer A. 
FM464 Analysis 
50 µL of FM464, a lipophilic fluorescent dye, was then added to each Eppendorf and 
then thoroughly mixed. The dye was then allowed to bind to the vesicles for 30 minutes, 
then mixed once again and placed on a magnetic separator. The solution was taken 
out and saved, then the beads were washed twice with Vesicle Buffer A, then washed 
with 500µL Elution buffer twice to remove the protein. The elution buffer solutions were 
placed into a 1 ml cuvette and compared visually, any color change was noted and 
saved for a fluorescence scan to accurately detect any dye remaining in the solutions 
WKDWZDVQ¶WYLVLEOH 
2.2.8 - Microscopy 
Samples were visualized using an Olympus IX71 microscope 
Standard Protocol 
A 2% Agarose solution was melted as 95°C, then 50 µL was pipetted onto a microscope 
slide, using a pro former to create a flat surface. Up to 20µL of samples were mounted 
on the agarose pads and allowed to dry slightly so as to mobilize them. A coverslip 
was gently placed and secured on top of the agarose pad and then samples were 
visualized using the Olympus IX71 microscope. 
SRB Red 
A 2% Agarose solution was melted at 95°C hot plate and a 1.5ml E ppendorf was filled 
with water and kept at 37°C. Once melted, the agarose was quickly diluted to 0.5% 
and the Eppendorf was kept at 37°C so it stayed molten.  0.01%  SRB Red was made 
up and added to the molten 0.5% agarose then pipette mixed carefully. 15 µL of the 
SRB-agarose was mixed into 500 µL of vesicles and 20µL of the agarose mix was 
pipetted onto a microscope slide and allowed to set. A cover slip was gently placed 
over the top of the agarose and secured, then vesicle samples were visualized using 
the Olympus IX71 Microscope using the appropriate filters.   
2.2.9 - Sedimentation Assay 
5µL of DPPE, DSPG and POPC vesicles were added into three separate 1.5ml 
eppendorfs. 40µL of Vesicle Buffer A and 5µL of TH1 protein were pipetted into each 
of these eppendorfs to make a total volume of 50µL. A protein control containing 5µL 
of TH1 protein and 45µL of Vesicle Buffer A was also set up and labelled. Eppendorfs 
were centrifuged at 10k for 30 minutes. The supernatant from each Eppendorf was 
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removed carefully and placed into a separate clearly labelled Eppendorf. The pellet 
was resuspended into 50µL of Vesicle Buffer A. 10µL of protein loading buffer was 
added to each of the 8 tubes. These were then run on a 10% SDS-PAGE gel for 60 
minutes and placed into coomassie stain and imaged once destained 
 
  












            Results  
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3.1 ± Hum-1 TH1 
3.1.1 ± Cloning of the TH1 Domain 
Initially, we needed to determine whether the TH1 domain and phospho-mutant were 
soluble and could be purified. If these proteins were expressing as expected then we 
would see a band at 27.5kDa on an SDS PAGE gel. Initially we used E. coli BL21 De3 
cells for expression, however, there was very little expression when the protein was 
induced with this strain (Figure 8A).  
In response to the lack of expression, we transformed our plasmids into BL21 Rosetta 
Pduet Cam 1 cells; a chloramphenicol resistant strain that co -expresses Calmodulin. 
As expression using this strain was successful (Figure 8B), the next step was to 
determine the best way to purify the protein.  
3.1.2 - TH1 Purification 
We started off by attempting purification under native conditions using a cobalt column. 
However, we discovered that a lot of protein was lost during purification, and when 
samples from each purification stage were run on an SDS PAGE gel, we realized that 
the protein was being lost in when it was loaded onto the column. This meant that the 
His-tag on the protein was not binding to the column. We then attempted to use a nickel 
column, however the same result was observed (Figure 9A). Since the protein was 
being expressed as normal, and assuming the His-tag was intact, we hypothesized 
that the protein might have been binding to the membrane lipids in the cells so was 
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Figure 8: Hum_1 TH1 expression. SDS PAGE gels were used to determine the success of protein 
inductions. A. TH1 expression using E. coli BL21 DE3. (Lane 1) Protein ladder, (Lane 2) Pre-induction 
sample, (Lanes 3-7) empty lanes, (Lane 8) post induction sample. Band expected at 27.5kDa, however 
there was no expression shown after a standard induction. C: TH1 expression using E. coli BL21 Cam-
1 pLysS. (Lane 1) Protein ladder. (Lane 2) Pre-induction sample (Lane 3) Post induction sample. Band 
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denaturing conditions, so that if the His-tag was damaged during one of the stages, 
the purification would fail, however if the protein was binding to lipids or other cell 
components in the cell, then this purification method would be successful. Therefore, 
we used this method for purification and our hypothesis was confirmed (Figure 9B) and 
the purification was successful. The protein was seen between 20 and 25 kDa, 
however this may be because while the protein is denatured it can travel easier through 
the gel, furthermore SDS gives a relative molecular mass rather than a true molecular 
mass so we determined that this was our protein. We then dialyzed the protein from 
the 8M urea elution buffer to Vesicle Buffer A, however, the protein quickly precipitated 
out of solution even with a slow dialysis, so we kept the protein in the urea buffer. This 
limited the experiments we could carry out with the protein, as the urea buffer would 
have denatured the protein, so any interactions could have been affected by this.  
 
3.1.3 ± Sedimentation assays to determine TH1 lipid binding properties 
Following this, we carried out some simple sedimentation assays using the purified 
TH1 domain, in order to determine the phospholipids that it interacts with and how that 
differs from the phospho-mutant. Sedimentation assays are assays based on the 
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Figure 9: Hum_1 TH1 Purification Gels. SDS 
PAGE gels were used to determine an effect 
purification method, which would be the method 
that had a better yield of protein. A. Purification 
under Native conditions: (Lane 1) protein 
ladder, (Lanes 2 ± 6) samples from the 
purification wash steps, (Lanes 7 ± 12) elutions 
1 to 6 respectively. No band is seen at the 
expected size of 27.5kDa, indicating a loss or 
lack of protein.  
B. Purification under denaturing conditions: 
(Lane 1) protein ladder (Lanes 2 ± 5) 
purification wash steps. (Lanes 6 ± 9) elutions 1 
± 4 respectively. Band is seen in between 20 
and 25 kDa.  
kDa 
kDa 
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sedimentation of vesicles and bound proteins when centrifuged [53]. If the protein 
binds to the lipid vesicles, both sediment to the bottom of the tube, forming a pellet that 
can be analyzed by running on an SDS PAGE gel. 
Initially we ran the TH1 with DSPG, DPPE and POPC vesicles, however, when run on 
an SDS PAGE gel, no difference between the three was observed (Figure 10A). We 
then set up a control of the protein alone to ensure that the protein did not sediment 
when centrifuged alone. We carried out this experiment at 4 centrifugation speeds; 
2000, 5000, 7500 and 10000 rpm. The supernatant was then removed and both the 
supernatant and pellet were analyzed using SDS PAGE. The protein was found in the 
pellet (Figure 10B). We repeated this, and observed the same result and thus 
concluded that we could not use sedimentation assays for this protein. Some 
membrane binding proteins tend to oligomerize or aggregate, which leads to 
sedimentation when centrifuged [53], which could be a possible reason for this assay 
being unsuccessful for the TH1 domain. 
 
 
3.1.4 ± Agarose Bead Assay to determine TH1 lipid binding properties 
Following the results of the sedimentation assays, ZHGHFLGHGWRXVH4LDJHQ¶V1L-NTA 
Magnetic Agarose Beads for a TH1 binding assay. We chose to do this as the His-tag 
on the protein can bind to the nickel coated agarose beads, and when placed on a 
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Figure 10: SDS PAGE gels from 
the sedimentation assay. A. 
Sedimentation assay with POPC, 
DSPG and DPPE lipid vesicles 
showing the pellets and 
supernatants.  (Lane 1) Protein 
ladder (Lane 2) Negative control 
pellet (Lane 3) Negative control 
supernatant (Lane 4) POPC pellet 
(Lane 5) POPC supernatant (Lane 
6) DSPG pellet (Lane 7) DSPG 
supernatant (Lane 8) DPPE pellet 
(Lane 9) DPPE supernatant. B. 
Sedimentation assay negative 
control. Protein spun without 
phospholipid. (Lanes 1, 3, 5 & 7)  
Protein pellet samples run at 2000, 
5000, 7500 and 10000 rpm 
respectively (Lanes 2, 4 & 6) 
Protein supernatant samples when 
run at 2000, 5000 and 7500 rpm 
respectively. At all speeds the 
protein sedimented into the pellet. 
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magnetic separator, the magnetic beads and bound protein would be attracted to the 
magnet, and the unbound protein could be removed. When the lipid vesicles were 
added, if they bound to the protein, a bead-protein-vesicle complex could be formed, 
and again the unbound vesicles could be separated and removed, leaving only the 
bound protein and vesicles. FM4-64, a lipophilic dye that would bind to the vesicles, 
was added to the protein samples to determine whether vesicles were present, which 
would tell us whether the TH1 interacted with any of the lipids. Figure 11 below is an 
image of the results from the FM464 analysis. Due to time constraints, we were unable 
to complete a full scan of each sample, which would have allowed us to determine 
whether there was FM464 present in each sample, thereby allowing us to determine 
the lipids that the protein interacts with. Quantification of FM464 in samples would allow 
us to accurately determine this as we were unable to do so visually. 
 
 
3.1.5 ± Neon Green tagged TH1  
As we were only able to purify the TH1 domain under denaturing conditions, we 
decided to visualize where it was localizing so as to determine whether this was due 
to it being bound to phospholipids or was localizing in the periplasmic space. We 
created a neon green TH1 wild type and Phospho-mutant so that we would be visible 
under a microscope and we could then potentially use this protein with other 
techniques, such as stopped flow, to determine its lipid interactions.  
As with the original TH1 and Phospho-mutant, expression was carried out in BL21 
Cam-1 cells until we had reached an optical density of 0.4. We then took 20µL of the 
cell culture and pipetted them onto an agarose pad on a microscope slide. Finally we 
visualized and imaged the cells under the microscope (Figures 12 & 13).  
The images revealed to us that the wild type TH1 domain was localizing in inclusion 
bodies at the poles of the cells (Figure 12), whereas the phospho-mutant was 
predominantly cytoplasmic (Figure 13). This difference in localization suggested that 
phosphorylation of TH1 may play a role in its localization. Further investigation into this 
would need to be carried out in order to fully understand this.  
Figure 11. Samples from the 
Agarose Bead Assay. Cuvettes 
containing Hum-1 TH1 with (A) 
DSPG, (B) DPPE, (C) POPC, (D) 
Negative control, (E) Vesicle Buffer 
A. Little visual difference observed. 
A                       B                  C                     D                    E 








Figure 12: Microscopy images of wild type Neon Green tagged Hum 1 TH1 
expression in BL21 Cam 1 cell. (A) Fluorescence image (B) Phase image. 
Fluorescence images show localization in inclusion bodies rather than in the 
cytoplasm. 
Figure 13: Microscopy images of Neon Green tagged Hum 1 TH1 phospho-
mutant expression in BL21 Cam 1 cells. (A) Fluorescence images (B) Phase 
images. Fluorescence image shows localization in the cytoplasm rather than 
around membranes or in inclusion bodies. 
A B 
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3.2 - Alpha Synuclein and its phospholipid interactions 
The next part of the project was to investigate how Į6\QXFOHLQ LQWHUDFWLRQV ZLWK
different phospholipids and determine whether its acetylation had any impact on these 
interactions. The acetylated and un-acetylated Į6\QXFOHLQ used were cloned, 
expressed and FPLC and His-tag purified by another member of the lab.  
3.2.1 ± DLS Experiments 
Dynamic light scattering is a technique used to study the behavior of molecules in 
solution [54]. A sample is exposed to a monochromatic light source such as a laser 
and a detector detects the light scattered by the sample, allowing us to determine the 
size profile of the sample [54]. We used unilamellar vesicles in the DLS to determine 
whether the protein interacted with the vesicles by adding Į6\QXFOHLQ to a solution of 
uniform vesicles. A negative control was initially taken so as to eliminate any changes 
that are solely due to the addition of protein, and we could observe the effect on the 
phospholipids only. 
DPPE 
While preparing vesicles made from this lipid, we discovered that it was highly 
unstable. Due to its hydrophobic nature, the lipid would form a layer along the top of 
the buffer rather than forming vesicles within the buffer. After sonication, we were able 
to dissolve some of the lipid, however after a short period of time, it would begin to 
precipitate out of solution and form a layer once again. When run through a DLS alone 
the data was inconsistent with each run (Figure 14A), in comparison to POPC vesicles 
that would produce the same reading with each run (Figure 14B) so as a result of this, 
we did not use this lipid in DLS experiments with Į6\QXFOHLQ until we could suspend them 











Dynamic Light Scattering: POPC Vesicles (1mM) 
10 repeats shown 
Figure 14: DLS Size-Intensity plots of vesicles in Vesicle Buffer A: (Graph A) Stable 
POPC vesicles that are ~ 100nm. Each repeat is consistent.  (Graph B) DPPE vesicles 
in Vesicle buffer A. Inconsistent readings; vesicles of different sizes within the sample 
and also larger than expected at ~500-600 nm.  
 
B 
Dynamic Light Scattering: DPPE Vesicles (1mM) 
10 repeats shown 
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POPC  
POPC formed stable vesicles that were ~100 nm in size (Figure 15), shown by a single 
peak slightly larger than 100 nm on an Intensity-Size plot. (This would appear slightly 
larger due to the hydrodynamic radius; the water molecules surrounding the vesicles). 
When acetylated Į6\QXFOHLQ ZDV DGGHG there was no significant change to the 
vesicles, on the other hand when un-acetylated Į6\QXFOHLQ ZDV DGGHG D slight 
broadening of the peak was seen, suggesting a greater size distribution (Figures 16A-
16B). However, this change could be due to the addition of protein. We then allowed 
the proteins to interact with the vesicles for 30 minutes and ran them through the DLS. 
For both un-acetylated and acetylated, two peaks were seen; one at 100 nm with a 
wider distribution and the other at 5000 nm (Figures 17A & B). The absence of 
intermediate sized vesicles suggested that the vesicles had formed aggregates rather 






Figure 15: DLS size-intensity Graph. POPC Vesicles in Vesicle Buffer A showing an average size of 
100nm, as expected. An average of 10 readings is shown. 
 

























Average of 10 readings shown 
POPC vesicles and Un-aFHW\ODWHGĮS 
Average of 10 readings shown 
Figure 16: Size-intensity plots of POPC vesicles (Average of 10 runs) with (A) Acetylated 
Į6\QXFOHLQ showing little change in size and (B) un-acetylated Į6\QXFOHLQ, showing a slight 
broadening which indicated a greater size distribution.  
 







Figure 17: Size intensity plots of POPC vesicles (Average of 10 runs) after 30 minutes of 
incubation with (A) un-acetylated Į6\QXFOHLQ and (B) acetylated Į6\QXFOHLQ. Both showing a 
slight increase in size and larger species at 5000nm, suggesting aggregation. Both also show 
a broadening of the size/intensity peaks, indicating a larger size distribution within the sample. 
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DSPG  
DSPG vesicles formed vesicles ~200 - 300 nm and had a tendency to form aggregates 
naturally; shown by two consistent peaks on an intensity-size plot - one at ~200 nm 
and the other at 5000 nm (Figures 18). Although multiple peaks were present with 
DSPG vesicles, this was consistent through all readings, so we were able to use them 
in DLS analysis. When acetylated Į6\QXFOHLQZDVDGGHGWRWKHYHVLFOHVWZRSHDNV
were consistently seen; one at ~ 600 nm and the other at ~13 nm (Figure 19). The 
peak at ~ 600 nm was roughly twice the size of the normal DSPG vesicles, potentially 
suggesting increased aggregate formation. The smaller vesicles, however, may have 
been lipid that could have been broken down from the larger aggregates and re-formed 
into smaller vesicles. Another possible explanation could be that the vesicles had been 
fused together by the acetylated Į6\QXFOHLQ, however the absence of intermediate sizes 
or gradual changes suggests that this may not be the case.  
As there was a difference in intensity-size plots for POPC when run after 30 minutes 
compared to being immediately run, we then decided to monitor the interaction on the 
'/6E\UXQQLQJWKH'63*YHVLFOHVZLWKDFHW\ODWHGĮ6\QXFOHLQUHSHDWHGO\WLPHV
This would allow us to see gradual changes in size, and may give an indication as to 
ZKHWKHU WKHDFHW\ODWHGĮ6\QXFOHLQZDV LQFUHDVLQJ'63*DJJUHJDWLRQRULQcreasing 
DSPG size. After 100 runs, the same two peaks were consistently seen on the 
Intensity-size plots (Figures 19A-19B). This suggests increased aggregate formation 
rather than increased size, however further experiments or microscopy would need to 
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Figure 18: Size-intensity plot of DSPG vesicles alone in vesicle buffer A (Average of 10 runs). 
Average size of species in this sample is 200 nm and a small peak at 5000 nm may suggest aggregate 
formation.  
 
Figure 19: Size-intensity plots of DSPG vesicles with acetylated Į6\QXFOHLQ: (A) Average of 10 
runs. (B) After 100 runs. An increase in size is observed and maintained after 100 runs. 
We then carried out the same DLS experiment with the un-acetylated Į6\QXFOHLQ. 
After one run, multiple peaks were seen on the intensity-size plot (Figure 20) 
indicating different sized vesicles. As with the acetylated Į6\QXFOHLQ, we ran these on 
the DLS 10 times (creating 100 individual readings). And plotted intensity-size graphs 
(Figures 21 A-H). The vesicles appear to increase in size, until they reach 5560 nm, 
at which point they burst. We hypothesize that the lipids from these large vesicles are 
either incorporated into the other vesicles or they reform into small vesicles that begin 
to fuse again. When following a single peak along, we can see this pattern more 
clearly (Figure 22); vesicles of various sizes appear to be fusing to form larger 
vesicles and bursting at 5000 nm. This result prompted us to begin imaging the 




Figure 20: Size intensity plot of 
DSPG vesicles with un-acetylated 
Į6\QXFOHLQ. Multiple peaks at 10 
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Figure 21: Size intensity plots of DSPG vesicles with un-acetylated Į6\QXFOHLQ monitored over 
100 runs. Each graph showing 10 individual runs, each set of 10 consecutively starting from graph A to 
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Figure 22: Vesicle size (nm) monitored over time (minutes). Vesicles appear to be growing in size 
until they reach ~5000 nm (5 microns), at which point they burst and reform into smaller vesicles, then 
begin to grow in size once again. 
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3.2.2 ± Microscopy using Synthetic vesicles 
We began to investigate the different ways to image the vesicles so that we could 
visualize WKHLU LQWHUDFWLRQ ZLWK Į6\QXFOHLQ ,QLWLDOO\ ZH XVHG WKH DJDURVH SDGV IRU
imaging the vesicles, however we were unable to take clear images due to the motility 
of the vesicles and their small size (~100-200 nm) made it difficult to differentiate 
between the agarose cracks and the vesicles. We then decided to use SRB Red, a 
fluorescent dye, to image the vesicles, as described by Lira R. B. et al 2016 in ³3RVLQJ
IRU D SLFWXUH 9HVLFOH LPPRELOLVDWLRQ LQ DJDURVH JHO´ [55]. The images were not as 
expected, the dye was being taken into the vesicles and make them fluorescent, and 
which made it difficult to distinguish between the fluorescence of the agarose and the 
vesicles. Due to this, we were unable to obtain clearer images of the vesicles (Figure 
23). The vesicles with acetylated DSPG, as with the other lipids, were too small to 







Figure 23: Microscope images of DSPG Vesicles with Un-acetylated Į6\QXFOHLQ. (A) Phase 
Images Vesicles were too small to distinguish. As there were holes within the agarose, so we were 
unable to obtain clearer images. (B) SRB Red fluorescence; some vesicles would take up the 
fluorescent compound, however there would also be spots of brightness within the agarose, so we were 
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3.2.3 - Stopped Flow Spectroscopy using Alpha Synuclein 
Stopped flow is a technique used to measure immediate kinetic changes that occur 
when two molecules interact with one another. We decided to use this technique as it 
would allow us to see any change to the vesicles ZKHQĮ6\QXFOHLQZDVUDSLGO\PL[HG
with the vesicles. We used the vesicles made up of the DSPG phospholipid, as they 
reacted the most with un-acetylated Į6\QXFOHLQ:HDOVRWHVWHGĮ6\QXFOHLQDWGLIIHUHQW
concentration to determine whether concentration had an impact on these interactions. 
This was done as in previous experiments by other members of the lab, the 
FRQFHQWUDWLRQ RI Į6\QXFOHLQ KDV JUHDWO\ LPSDFWHG LQWHUDFWLRQV ZLWK FHOOXODU
membranes.  
:HXVHGD%UDGIRUGDVVD\DFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQVWRFRPSDUH
the concentrations of the stock acetylated and un-acetylated Į6\QXFOHLQ)LJXUH), 
which revealed that their protein concentrations were similar, however un-acetylated 
Į6\QXFOein was slightly higher (Table 2).  
 
Figure 24: Bradford Assay for protein concentration. The standard curve is shown in blue, whilst 
un-acetylated Į6\QXFOHLQ (0.64 mg/mL), is shown in red and aFHW\ODWHGĮ6\QXFOHLQ (0.54 mg/mL) is 
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 OD 595 Protein concentration (mg/ml) 
$FHW\ODWHGĮ6 0.2093 0.54 
Un-acetylated Į6 0.2455 0.64 
7DEOH Į6\QXFOHLQ SURWHLQ FRQFHQWUDWLRQV determined using the Bradford 
assay. Their optical densities were compared to the standard curve in Figure 24 
to obtain their concentration. 
 
:HWKHQPDGHXSWKUHHFRQFHQWUDWLRQVRIHDFKSURWHLQѿ00DQG0DQGused 
these in the stopped flow experiments, monitoring light scattering changes at 545nm 
and fluorescence changes at 436nm.  
We began with the analysis oIDFHW\ODWHGĮ6\QXFOHLQDQGDSPG; the concentration of 
which was maintained at 1mM. At a protein concentration of 1µM, two distinct phases 
are observed (Figure 25). A rapid initial phase, shown by a rapid decline in amplitude 
(A1) of -2.56301 and high initial rate (R1) of 19.21794 followed by a slower secondary 
phase, shown by a much more gradual decrease in amplitude (A2) of -1.79428 and 
the secondary rate (R2) of 1.88927.   
At 3 µM (Figure 26), only one phase is detected. The amplitude of this phase (A) which 
was -0.67018, is far lower than the amplitude of the initial phase when tested at 1µM, 
but faster than the secondary phase. This could be due to the initial phase decelerating 
or the slow phase had accelerating. At 3µM, the initial rate appears to have decreased 
significantly (R1), and as there is little or no secondary phase, there is no rate for the 
secondary phase.  
Light scattering data was variable making it difficult to monitor, however a similar 
pattern was seen when the measurement graphs were overlaid over one another 
(Figure 27). 7KHOLJKWVFDWWHULQJDWѿ0ZRXOGLQFUHDVHUDSLGO\IROORZHGE\DJUDGXDO
decrease and then would stay at the same level, whereas at 1 µM, there would be an 
initial increase and the second phase of this data would vary; increasing in some 
measurements or decreasing in other measurements. The conclusion we reached from 
WKLV ZHUH WKDW FRQFHQWUDWLRQ RI WKH DFHW\ODWHG Į6 GLG PDNH D GLIIHUHQFH WR WKH
fluorescence, indicating a some kind of binding event, and concentration appeared to 
alter this interaction, particularly the secondary event. Due to the variability of the light 
scattering data, further analysis is required to make any conclusions from the data 
collected. Light scattering data using the acetylated protein with the vesicles over the 
same time period as the un-acetylated protein would also need to be collected.  
 















A1 A2 R1 R2 
Value -2.56301 -1.79428 19.21794 1.88927 
Figure 25: (A) Stopped Flow Fluorescence graph showing the interaction between acetylated 
Į6\QXFOHLQat 1 µM and DSPG vesicles at 1mM. Two phases clearly observed; a rapid initial phase 
and a slower secondary phase. (B) Corresponding Fit parameter values. A1 = Amplitude of initial 















Fit Parameter Name A R 
Value -0.67018 6.64585 
Figure 26: (A) Stopped flow fluorescence graphs showing the interaction between DSPG 
vesicles at 1mM and DFHW\ODWHGĮ6\QXFOHLQDW 3µM. Average of 4 datasets is shown. Only one 
phase recorded, and a much lower amplitude for the slower phase when compared to the data at 
1µM. (B) Corresponding Fit Parameter values: A = Amplitude, R1 = Rate 
B 
A 
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  Figure 27: Stopped Flow Light Scattering graphs. (A) $FHW\ODWHGĮ6\QXFOHLQDW0
interacting with DSPG vesicles at 1mM. Light scattering would increase initially, however in 
the second phase, this would vary, increasing gradually in some measurements (green and 
blue lines) or decreasing gradually in other measurements (red line) (B) acetylated 
Į6\QXFOHLQDWѿ0LQWHUDFWLQJZLWK'63*YHVLFOHVDW 1mM over a longer time period (10 
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We then began analysis of the un-acetylated Į6\QXFOHLQZLWK'63*YHVLFOHV (Figures 
28 - 30).  
The fluorescence for all three concentrations had revealed two phases. Similar to the 
acetylated protein, a rapid initial phase was observed (A1 and R1) and a more gradual 
secondary phase was REVHUYH$DQG5$Wѿ0WKHDPSOLWXGHRIWKHLQLWLDOSKDVH
(describing change in fluorescence) was -2.69962, this decreased at 1µM which was -
2.34839 but increased at 3µM to -2.75245. The rate, however, of the initial phase (R1) 
IRUѿ0ZDV19.73524, which increased to 22.52082 at 1µM and then increased to 
28.17782 at 3µM. This suggests that the initial event, which could possibly be binding, 
speeds up with increasing concentrations of un-acetylated Į6\QXFOHLQ, however, further 
experiments would need to be carried out in order to understand the decrease in 
DPSOLWXGHIURPѿ0WR0DQGWKHQWKHLQFUHDVHIURP0WR07KHDPSOLWXGH 
change RIWKHVHFRQGDU\SKDVHDWѿ0(A2) was -1.54217, which then decreased to 
-0.54706 at 1µM and then decreased again at 3µM to -0.43028. The rate of the 
VHFRQGDU\SKDVH5DWѿ0ZDV1.18162, which then decreased to 1.16064 at 1µM 
and further decreased at 3µM to 1. So the rate and amplitude both decreased with 
increasing concentration, suggesting that the second event slows down with increasing 
concentration and there is a lower change in fluorescence with increasing 
concentration. Potentially, this could suggest that the increase in concentration 
negatively affects the secondary event. 
From this data, a concentration dependent interaction is seen. At all concentrations, 
two distinct phases are seen.  
When carrying out light scattering experiments using Į6\QXFOHLQDWERWK0DQG0 
in the absence of vesicles (Figure 31), both traces showed too much noise to make 
conclusive statements, so light scattering experiments were not carried out. With more 
time, an investigation into the possible reasons for this would need to be carried out in 
























A1 A2 R1 R2 
Value 
-2.69962 -1.54217 19.73524 1.18162 
Figure 28. (A) Averaged fluorescence graphs showing the interaction between un-acetylated 
Į6\QXFOHLQ DWѿ0DQG'63*YHVLFOHVDWP0(B) Corresponding fit parameter values. A1 = 
Amplitude of the initial phase, A2 = amplitude of the secondary phase, R1 = Rate of the initial 









A1 A2 R1 R2 




Figure 29: (A) Stopped flow fluorescence graphs showing the interaction between un-acetylated 
Į6\QXFOHLQDW0DQG'63*YHVLFOHV at 1mM. Two distinct phases observed, however a faster 
initial rate and a slower rate for the secondary phase when compared to the lower concentration. 
(B) The corresponding fit Parameter values. A1 = Amplitude of the initial phase, A2 = amplitude 
of the secondary phase, R1 = Rate of the initial phase and R2 = Rate of the secondary phase. Two 
distinct phases, suggesting two distinct events occurring. 
A 
B 
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Figure 30. (A) Stopped flow Fluorescence graphs (Average of multiple traces) 
showing the interaction of un-acetylated Į6\QXFOHLQDW 3µM. A much faster initial rate (A1 
and R1) and slower secondary phase (A2 and R3) observed when compared to the two 
lower concentrations.  (B) Corresponding fit parameter values. A1 = Amplitude of the 
initial phase, A2 = amplitude of the secondary phase, R1 = Rate of the initial phase and R2 
= Rate of the secondary phase.  
B 
A 













Figure 31: (A) Stopped Flow light scattering graph for un-DFHW\ODWHGĮ6\QXFOHLQDW
3µM in the absence of vesicles (B) Stopped flow light scattering graph for un-
DFHW\ODWHGĮ6\QXFOHLQDW0 run in the absence of vesicles. Traces showed too much 
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4.1 ± Hum 1 TH1 Expression and Purification 
Myosin 1 subgroups have been shown to vary in function [20, 56], and the presence 
of the TH1 domain may have a part to play in this, as it has been shown to interact with 
phospholipids [57]. Understanding the TH1 domain and the difference post 
translational modifications make to its interactions is important in understanding 
diseases and also in understanding other similar proteins. From our data we can see 
that the localization of TH1 and the phosphorylated TH1 were different. Although we 
successfully cloned, expressed and purified the TH1 domain and the phospho-mutant, 
we were only able to see the basic interactions that the TH1 domain has with 
phospholipids. This will provide a basis for future experiments, however future steps in 
this project would be to use the neon green TH1 in stopped flow and DLS experiments 
with different phospholipids and compare this with the Neon green phosphomutant and 
time lapse imaging of the vesicles at a higher magnification. The TH1 domain also has 
other post translational modifications, so we could look into how they impact Myosin 
interactions and localization.  
4.2 ± Hum 1 TH1 Microscopy 
As we were unable to clearly visualize vesicles using the SRB imaging technique [55], 
microscopy experiments with the TH1 domain and different lipid vesicles were not 
carried out. Further improvement of the microscopy technique would allow us to 
determine the interaction between the TH1 domain with different phospholipids and 
the effect of phosphorylation, as well as with other post translational modifications. The 
microscopy images revealed a difference in the localization in the phosphorylated and 
wild type TH1, which could be due to the phosphate group increasing solubility in 
solutions by changing the overall charge of the molecule. Furthermore, the creation of 
the neon green TH1 would allow us to better visualize the protein. Improvement of this 
technique would allow us not only to understand the TH1 domain, but other lipid binding 
proteins whose functions are still unknown, which would benefit the scientific 
community greatly, as it would allow us to clearly visualize protein-lipid activity.  
4.3 ± Hum 1 TH1 Vesicle Studies 
As shown within this thesis, the sedimentation assays were unsuccessful in 
determining the interactions the TH1 domain has with various phospholipids. This 
could be due to the purification method keeping the protein denatured, so it may not 
have been able to interact with the phospholipids. Optimizing protein expression and 
purification so that we have natively purified protein could allow us to carry out these 
experiments. We may also be able to test the TH1 domain against PIP strips, which 
are nitrocellulose membranes with different phospholipids attached to the surface. 
However the as DLS studies and co-flotation assays better mimic physiological 
conditions [58], these techniques would be preferred as they could give us more 
accurate results [59]. The FM4-64 analysis was unclear, as visual determination of the 
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presence of the dye was difficult. This could be due to the small amount of the dye 
being present within the sample, which could have been too dilute to visualize by eye. 
To overcome this, a full fluorescence scan could be carried out so as to determine the 
presence of even the smallest amount of dye. However, the Neon green TH1 will allow 
us to produce more quantifiable data with other simpler techniques, will allow us to 
track the interactions and possibly visualize them, so we would not take the FM464 
analysis method forward for future experiments. 
4.4 - Alpha Synuclein 
Our data revealed a significant difference in the interactions that the acetylated and 
un-acetylated Į6\QXFOHLQ had. The DLS studies appeared to suggest that the acetylated 
Į6\QXFOHLQ would either not interact with the phospholipids (in particular POPC) or in 
the case of DSPG appeared to mainly aggregate vesicles. However when compared 
to the stopped flow data, the protein would bind to the vesicles and there would be 
another event occurring after this. A possible explanation could be that acetylated 
Į6\QXFOHLQ does interact with DSPG, however no change to the shape or size of the 
vesicles happens. If the protein is causing vesicle aggregation, then this could explain 
the changes we see with DLS experiments, and the two phases seen when stopped 
flow was carried out. Carrying out further experiments, in particular microscopy, once 
optimized, could allow us to determine whether this is the case. However, this could 
push research forward; if acetylation of Į6\QXFOHLQ causes aggregation, this could 
explain the Lewy bodies seen in PD and could play a part in the pathogenesis of PD. 
Our experiments with un-acetylated Į6\QXFOHLQ may help us to understand the 
physiological function of Į6\QXFOHLQ. Our DLS studies suggested that the protein was 
fusing DSPG vesicles together, but not others. Our hypothesis was further solidified 
when the DLS studies were compared to the stopped flow data. This was because two 
distinct phases were observed with stopped flow, which could be the initial binding 
followed by vesicle fusion. As mentioned previously, further development of the 
microscopy technique would allow us to visualize the fusion and would push research 
in this area forward, as the physiological function of Į6\QXFOHLQ is still uncertain. And as 
this finding is similar to previous work carried out by other members of the lab, we may 
be able to determine the function of Į6\QXFOHLQ which would make a way for new 
WUHDWPHQWVRUHYHQSUHYHQWLRQRI3DUNLQVRQ¶VGLVHDVH 
Further work with Į6\QXFOHLQ would be to determine the reasons for varied light 
scattering data, microscopy imaging with lipid vesicles to determine their interactions, 
in particular DSPG vesicles. We could also collect data for the both proteins at gradual 
increases in concentration, and use fluorescent vesicles to monitor how this compares 
to the data retrieved for non-fluorescent vesicles. A breakthrough in this area, as 
PHQWLRQHG DERYH ZRXOG DOORZ XV WR XQGHUVWDQG 3DUNLQVRQ¶V SDWKRJHQHVLV DQG
potentially cure or treat it.  
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4.5 ± Conclusion 
Our aim in this study was to increase an understanding into how various membrane 
binding proteins may interact in physiological conditions, using lipid vesicles as models 
for this. We were able to add knowledge into these areas, in particular with Į6\QXFOHLQ, 
whose function is still uncertain. Although we would need to carry out more 
experiments to confirm this, we found that Į6\QXFOHLQ, when un-acetylated, bound 
more strongly to DSPG vesicles, and may have caused them to fuse (seen by our 
stopped flow data and DLS data). Understanding how it is doing this and why may give 
us insight into its function. We were not able to make any definitive conclusions with 
the TH1 domain, and would need to express and purify this natively before we can do 
so. 
Further work using lipid vesicles will also allow us to predict at a very basic level, which 
phospholipids and therefore membranes that these proteins can interact with and also 
understand mutations or imbalances that lead to their inability to function properly.  
Understanding membrane binding proteins, their functions and regulation allows us to 
gain a deeper understanding into how the human body works, and also gives us an 
understanding of diseases. This leads to more effective cures or treatments, 
preventative strategies for and potentially reversal of harmful diseases. Although we 
encountered various obstacles during this project, we were able to learn more about 
these proteins and as more research is carried out in these areas, this knowledge may 
have many applications in the future. 
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